Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthay

Showing results (1111-1120 of 1,339) with videos related to

Pageof 134
Sort By:
The European Respiratory Journal|October 18, 2019
Peripheral blood leukocyte telomere length is associated with survival of sepsis patientsShuo Liu, Chunxue Wang, Gary Green, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 21, 2019
Study of Unilateral Retinoblastoma With and Without Histopathologic High-Risk Features and the Role of Adjuvant Chemotherapy: A Children's Oncology Group StudyPatricia Chévez-Barrios, Ralph C Eagle, Mark Krailo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2011
Vorinostat increases expression of functional norepinephrine transporter in neuroblastoma in vitro and in vivo model systemsSwati S More, Melissa Itsara, Xiaodong Yang, et al.
Biorxiv : the Preprint Server for Biology|June 22, 2026
Secreted ORF8 reprograms macrophages to enhance SARS-CoV-2 infection of lung epithelial cellsYusuke Matsui, Rahul K Suryawanshi, Mauricio Montano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 2018
Defining Risk Factors for Chemotherapeutic Intervention in Infants With Stage 4S Neuroblastoma: A Report From Children's Oncology Group Study ANBL0531Clare J Twist, Arlene Naranjo, Mary Lou Schmidt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2012
Phase I study of vincristine, irinotecan, and ¹³¹I-metaiodobenzylguanidine for patients with relapsed or refractory neuroblastoma: a new approaches to neuroblastoma therapy trialSteven G DuBois, Louis Chesler, Susan Groshen, et al.
Pediatric Blood & Cancer|September 11, 2010
Thyroid and hepatic function after high-dose 131 I-metaiodobenzylguanidine (131 I-MIBG) therapy for neuroblastomaAlekist Quach, Lingyun Ji, Vikash Mishra, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 26, 2014
Metastatic neuroblastoma confined to distant lymph nodes (stage 4N) predicts outcome in patients with stage 4 disease: A study from the International Neuroblastoma Risk Group DatabaseDaniel A Morgenstern, Wendy B London, Derek Stephens, et al.
International Journal of Radiation Oncology, Biology, Physics|January 10, 2017
Patterns of Relapse in High-Risk Neuroblastoma Patients Treated With and Without Total Body IrradiationRichard Li, Alexei Polishchuk, Steven DuBois, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 28, 2009
Phase I trial of oral irinotecan and temozolomide for children with relapsed high-risk neuroblastoma: a new approach to neuroblastoma therapy consortium studyLars M Wagner, Judith G Villablanca, Clinton F Stewart, et al.
Pageof 134

Showing results (1111-1120 of 1,339) with videos related to

Sort By:
Pageof 134
The European Respiratory Journal|October 18, 2019
Peripheral blood leukocyte telomere length is associated with survival of sepsis patientsShuo Liu, Chunxue Wang, Gary Green, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 21, 2019
Study of Unilateral Retinoblastoma With and Without Histopathologic High-Risk Features and the Role of Adjuvant Chemotherapy: A Children's Oncology Group StudyPatricia Chévez-Barrios, Ralph C Eagle, Mark Krailo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2011
Vorinostat increases expression of functional norepinephrine transporter in neuroblastoma in vitro and in vivo model systemsSwati S More, Melissa Itsara, Xiaodong Yang, et al.
Biorxiv : the Preprint Server for Biology|June 22, 2026
Secreted ORF8 reprograms macrophages to enhance SARS-CoV-2 infection of lung epithelial cellsYusuke Matsui, Rahul K Suryawanshi, Mauricio Montano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 2018
Defining Risk Factors for Chemotherapeutic Intervention in Infants With Stage 4S Neuroblastoma: A Report From Children's Oncology Group Study ANBL0531Clare J Twist, Arlene Naranjo, Mary Lou Schmidt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2012
Phase I study of vincristine, irinotecan, and ¹³¹I-metaiodobenzylguanidine for patients with relapsed or refractory neuroblastoma: a new approaches to neuroblastoma therapy trialSteven G DuBois, Louis Chesler, Susan Groshen, et al.
Pediatric Blood & Cancer|September 11, 2010
Thyroid and hepatic function after high-dose 131 I-metaiodobenzylguanidine (131 I-MIBG) therapy for neuroblastomaAlekist Quach, Lingyun Ji, Vikash Mishra, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 26, 2014
Metastatic neuroblastoma confined to distant lymph nodes (stage 4N) predicts outcome in patients with stage 4 disease: A study from the International Neuroblastoma Risk Group DatabaseDaniel A Morgenstern, Wendy B London, Derek Stephens, et al.
International Journal of Radiation Oncology, Biology, Physics|January 10, 2017
Patterns of Relapse in High-Risk Neuroblastoma Patients Treated With and Without Total Body IrradiationRichard Li, Alexei Polishchuk, Steven DuBois, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 28, 2009
Phase I trial of oral irinotecan and temozolomide for children with relapsed high-risk neuroblastoma: a new approach to neuroblastoma therapy consortium studyLars M Wagner, Judith G Villablanca, Clinton F Stewart, et al.
Pageof 134